相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacogenetics of Response to Antipsychotics in Patients with Schizophrenia
Maria J. Arranz et al.
CNS DRUGS (2011)
The role of serotonin receptors in the action of atypical antipsychotic drugs
H. Y. Meltzer et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction
Jian-Ping Zhang et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients
Ilja Spellmann et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2011)
Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis
Andrea Cipriani et al.
LANCET (2011)
Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics
J. L. McClay et al.
MOLECULAR PSYCHIATRY (2011)
Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia
Joseph L. McClay et al.
NEUROPSYCHOPHARMACOLOGY (2011)
D2 Receptor Genetic Variation and Clinical Response to Antipsychotic Drug Treatment: A Meta-Analysis
Jian-Ping Zhang et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Identification of Novel Candidate Genes for Treatment Response to Risperidone and Susceptibility for Schizophrenia: Integrated Analysis Among Pharmacogenomics, Mouse Expression, and Genetic Case-Control Association Approaches Masashi Ikeda
Masashi Ikeda et al.
BIOLOGICAL PSYCHIATRY (2010)
N-methyl-D-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?
Joshua T. Kantrowitz et al.
BRAIN RESEARCH BULLETIN (2010)
Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant
R. Hwang et al.
PHARMACOGENOMICS JOURNAL (2010)
Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism
Joanna C. Neill et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Serotonin transporter polymorphisms and early response to antipsychotic treatment in first episode of psychosis
Javier Vazquez-Bourgon et al.
PSYCHIATRY RESEARCH (2010)
Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis
Anna C. Need et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2009)
Applicability of a Genetic Signature for Enhanced Iloperidone Efficacy in the Treatment of Schizophrenia
Simona Volpi et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study
C. Lavedan et al.
MOLECULAR PSYCHIATRY (2009)
Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia
Rainald Moessner et al.
PHARMACOGENETICS AND GENOMICS (2009)
The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variation
Lingjun Zuo et al.
PHARMACOGENETICS AND GENOMICS (2009)
Influence of 5-HT3 receptor subunit genes HTR3A, HTR3B, HTR3C, HTR3D and HTR3E on treatment response to antipsychotics in schizophrenia
Anna Schuhmacher et al.
PHARMACOGENETICS AND GENOMICS (2009)
Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia
B. A. Fijal et al.
PHARMACOGENOMICS JOURNAL (2009)
No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients
Hwa-Young Lee et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
The serotonin transporter gene and disease modification in psychosis: Evidence for systematic differences in allelic directionality at the 5-HTTLPR locus
Terry E. Goldberg et al.
SCHIZOPHRENIA RESEARCH (2009)
Pharmacogenetic study of atypical antipsychotic drug response:: Involvement of the norepinephrine transporter gene
A. Meary et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2008)
Excess of transmission of the G allele of the-1438A/G polymorphism of the 5-HT2A receptor gene in patients with schizophrenia responsive to antipsychotics
Dalila Benmessaoud et al.
BMC PSYCHIATRY (2008)
Dopamine receptor D3 genotype association with greater acute positive symptom remission with olanzapine therapy in predominately caucasian patients with chronic schizophrenia or schizoaffective
David H. Adams et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
The-1019 C/G polymorphism of the 5-HT1A receptor gene is associated with negative symptom response to risperidone treatment in schizophrenia patients
L. Wang et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Model-based gene selection shows engrailed 1 is associated with antipsychotic response
Bradley Todd Webb et al.
PHARMACOGENETICS AND GENOMICS (2008)
BDNF gene is a genetic risk factor for schizophrenia and is related to the chlorpromazine-induced extrapyramidal syndrome in the Chinese population
Ming-Qing Xu et al.
PHARMACOGENETICS AND GENOMICS (2008)
G-protein gene 825C > T polymorphism is associated with response to clozapine in Brazilian schizophrenics
Fabiana B. Kohlrausch et al.
PHARMACOGENOMICS (2008)
Acute antipyschotic efficacy and side effects in schizophrenia: Association with serotonin transporter promoter genotypes
Vita Dolzan et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Effects of the dopamine D-3 receptor (DRD3) gene polymorphisms on risperidone response: A pharmacogenetic study
Jiekun Xuan et al.
NEUROPSYCHOPHARMACOLOGY (2008)
The impact of pharmacogenetics on the development and use of antipsychotic drugs
Gavin P. Reynolds
DRUG DISCOVERY TODAY (2007)
Dopamine transporter polyrnorphisms and risperidone response in Chinese schizophrenia patients: an association study
Aiping Zhang et al.
PHARMACOGENOMICS (2007)
Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics:: a serotonergic approach
Sami Anttila et al.
BMC PSYCHIATRY (2007)
Response of risperidone treatment may be associated with polymorphisms of HTT gene in Chinese schizophrenia patients
Lei Wang et al.
NEUROSCIENCE LETTERS (2007)
COMT Val(158) Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia
Alessandro Bertolino et al.
SCHIZOPHRENIA RESEARCH (2007)
Effect of 5-HT1A receptor gene polymorphism on negative and depressive symptom response to antipsychotic treatment of drug-naive psychotic patients
Gavin P. Reynolds et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Pharmacogenetics of schizophrenia
Gavin P. Reynolds et al.
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder
XZ Hu et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Suggestive association between the C825T polymorphism of the G-protein β3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia
DJ Müller et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2005)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment
JR Bishop et al.
SCHIZOPHRENIA RESEARCH (2005)
The-1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity
MJ Parsons et al.
BIOLOGICAL PSYCHIATRY (2004)
Receptor mechanisms in the treatment of schizohrenia
GP Reynolds
JOURNAL OF PSYCHOPHARMACOLOGY (2004)
Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response
S Lemonde et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
Catechol-O-methyltransferase Val108/158Met genotype predicts working memory response to antipsychotic medications
TW Weickert et al.
BIOLOGICAL PSYCHIATRY (2004)
Selective serotonin re-uptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia
H Silver
EXPERT OPINION ON PHARMACOTHERAPY (2004)
Pharmacogenetics of psychotropic drug response
AK Malhotra et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Olanzapine: concordant response in monozygotic twins with schizophrenia
I Mata et al.
BRITISH JOURNAL OF PSYCHIATRY (2001)
Pharmacogenetic prediction of clozapine response
MJ Arranz et al.
LANCET (2000)
分享论文
